SYRE
Spyre Therapeutics Inc.
79.90$
-1.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | 100.0% | – | – | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 99.1% | 1,061.7% | 13.8% | 36.5% | 76.0% | 288.5% | 291.7% | 276.8% | 60.5% | – | 92.5% | – | – | – | – | – | – | – | 50.0% | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | 0.9% | -961.7% | 86.2% | 63.5% | 24.0% | -188.5% | -191.7% | -176.8% | 100.0% | – | 7.5% | – | – | – | – | – | – | – | 50.0% | – | – | – | |
| 468.7% | 380.2% | 504.0% | 394.5% | 494.8% | 390.8% | 455.0% | 383.6% | – | – | – | – | – | – | – | – | – | – | – | 99.1% | 1,061.7% | 460.5% | 1,246.5% | 2,459.7% | 6,883.3% | 8,482.7% | 6,957.6% | 2,527.0% | – | 3,232.4% | – | – | – | – | – | – | – | 49.3% | – | – | 238.5% | |
| 179.7% | 164.3% | 240.7% | 159.8% | 239.5% | 156.3% | 191.1% | 123.0% | – | – | – | – | – | – | – | – | – | – | – | 49.8% | 488.8% | – | – | – | 3,995.4% | 3,023.2% | 2,640.4% | 1,753.2% | – | 1,350.5% | – | – | – | – | – | – | – | 13.9% | – | – | 61.4% | |
| 648.4% | 544.5% | 744.7% | 554.4% | 734.3% | 547.1% | 646.0% | 506.6% | – | – | – | – | – | – | – | – | – | – | – | 49.8% | 488.8% | 647.2% | 1,858.0% | 3,611.7% | 10,590.2% | 11,214.3% | 9,321.2% | 23,246.2% | – | 4,406.3% | – | – | – | – | – | – | – | 113.2% | – | – | 222.5% | |
| -548.4% | -444.5% | -644.7% | -454.4% | -634.3% | -447.1% | -546.0% | -406.6% | – | – | – | – | – | – | – | – | – | – | – | -49.0% | -1,450.5% | -561.0% | -1,794.5% | -3,587.7% | -10,778.7% | -11,406.0% | -9,498.0% | -23,146.2% | – | -4,406.3% | – | – | – | – | – | – | – | -63.2% | – | – | -222.5% | |
| -542.9% | -439.7% | -636.2% | -448.4% | -624.4% | -437.4% | -537.7% | -395.9% | – | – | – | – | – | – | – | – | – | – | – | -49.2% | -1,449.7% | -560.5% | -1,794.1% | -3,570.2% | -10,599.4% | -11,181.0% | -9,322.2% | -31,551.5% | – | -6,063.3% | – | – | – | – | – | – | – | -69.1% | – | – | -197.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.7% | 1.9% | 0.6% | – | 1.4% | -120.1% | 22.6% | -18.2% | 1.0% | – | -551.4% | – | – | – | – | – | – | – | 0.0% | – | – | – | |
| -542.9% | -439.7% | -636.2% | -448.4% | -624.4% | -437.4% | -537.7% | -395.9% | – | – | – | – | – | – | – | – | – | – | – | -49.9% | -1,451.5% | -561.1% | -1,794.1% | -3,571.7% | -10,479.3% | -11,203.6% | -9,304.0% | -31,552.5% | – | -6,063.3% | – | – | – | – | – | – | – | -69.1% | – | – | -197.7% | |
| -545.4% | -441.6% | -639.4% | -450.2% | -628.8% | -442.6% | -541.4% | -403.5% | – | – | – | – | – | – | – | – | – | – | – | -46.3% | -1,420.2% | -546.7% | -1,757.6% | -3,494.2% | -10,310.9% | -10,889.3% | -9,045.5% | -4,119.8% | – | -4,582.9% | – | – | – | – | – | – | – | -69.1% | – | – | -205.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.